Transmission of hepatitis A to patients with hemophilia by factor VIII concentrates treated with organic solvent and detergent to inactivate viruses. The Italian Collaborative Group
- PMID: 7504424
- DOI: 10.7326/0003-4819-120-1-199401010-00001
Transmission of hepatitis A to patients with hemophilia by factor VIII concentrates treated with organic solvent and detergent to inactivate viruses. The Italian Collaborative Group
Abstract
Objective: To determine whether an outbreak of hepatitis A virus (HAV) infection that occurred in 52 patients with hemophilia in Italy was acquired through infusion of contaminated factor VIII or through environmental enteric transmission.
Design: A case-control study and a molecular analysis of HAV sequences from implicated lots of factor VIII and from infected patients.
Patients: The first 29 patients with hemophilia and jaundice in whom hepatitis A developed were compared with one to three matched controls with hemophilia but no jaundice.
Measurements: Type of concentrate and batches infused, number of doses, contacts with persons who had jaundice or hepatitis A, travel abroad to countries reported to have a high attack rate for hepatitis A, and consumption of raw shellfish. Hepatitis A viral sequences sought by polymerase chain reaction in lots of factor VIII and in serial serum samples from two patients with hemophilia in whom hepatitis A developed. Amplification by polymerase chain reaction of cDNA transcribed with reverse transcriptase from matched sets of factor VIII and recipient serum samples. Determination of nucleotide sequence of amplified hepatitis A virus genome.
Main results: Case patients were neither more nor less likely than controls to have traveled to high-risk countries, consumed raw shellfish, or had contact with persons with jaundice. Case patients were more likely than controls to have received a factor VIII concentrate treated with a solvent-detergent mixture to inactivate viruses (odds ratio, infinity; 95% CI, 4.5 to infinity) and to have had larger infusions of the concentrate during the presumed HAV incubation period (odds ratio, 8.54; CI, 2.78 to 27.5). Hepatitis A viral sequences were found in 5 of 12 tested lots of factor VIII. Genomic sequences of HAV obtained for two matched sets of factor VIII and recipient serum samples were identical within each set but different for the two sets.
Conclusion: Hepatitis A was transmitted by a factor VIII concentrate treated by a virucidal method (solvent-detergent) that ineffectively inactivates nonenveloped viruses.
Comment in
-
Transmission of hepatitis viruses.Ann Intern Med. 1994 Jan 1;120(1):82-4. doi: 10.7326/0003-4819-120-1-199401010-00014. Ann Intern Med. 1994. PMID: 8250462 No abstract available.
Similar articles
-
Virology of the hepatitis A epidemic in Italy.Vox Sang. 1994;67 Suppl 4:2-7; discussion 24-6. Vox Sang. 1994. PMID: 7831866
-
The outbreak of hepatitis A in Italian patients with hemophilia: facts and fancies.Vox Sang. 1994;67 Suppl 1:31-5. Vox Sang. 1994. PMID: 8091734
-
An outbreak of hepatitis A among South African patients with hemophilia: evidence implicating contaminated factor VIII concentrate as the source.Hepatology. 1995 Nov;22(5):1363-7. Hepatology. 1995. PMID: 7590648
-
Review of the hepatitis A epidemics in hemophiliacs in Europe.Vox Sang. 1994;67 Suppl 4:8-11; discussion 24-6. Vox Sang. 1994. PMID: 7831867 Review.
-
Sequence variability of hepatitis A virus and factor VIII associated hepatitis A infections in hemophilia patients in Europe. An update.Vox Sang. 1994;67 Suppl 1:39-45; discussion 46. Vox Sang. 1994. PMID: 8091736 Review.
Cited by
-
High cost, low volume care in haemophilia.BMJ. 1998 May 2;316(7141):1391. doi: 10.1136/bmj.316.7141.1391a. BMJ. 1998. PMID: 9564014 Free PMC article. No abstract available.
-
Hemophilia and von Willebrand's disease: 1. Diagnosis, comprehensive care and assessment. Association of Hemophilia Clinic Directors of Canada.CMAJ. 1995 Jul 1;153(1):19-25. CMAJ. 1995. PMID: 7796372 Free PMC article. Review.
-
State of care for hemophilia in pediatric patients.Paediatr Drugs. 2002;4(3):149-57. doi: 10.2165/00128072-200204030-00002. Paediatr Drugs. 2002. PMID: 11909007 Review.
-
Pathogen inactivation and removal methods for plasma-derived clotting factor concentrates.Transfusion. 2014 May;54(5):1406-17. doi: 10.1111/trf.12423. Epub 2013 Sep 30. Transfusion. 2014. PMID: 24117799 Free PMC article. Review.
-
The History of Hepatitis A.Clin Liver Dis (Hoboken). 2020 Oct 7;16(Suppl 1):12-23. doi: 10.1002/cld.1018. eCollection 2020 Oct. Clin Liver Dis (Hoboken). 2020. PMID: 33042523 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical